Cardioprotective efficacy of amifostine (WR-2721) in adriamycine-treated rats

被引：0
|
作者：
Dobric, S
DragojevicSimic, V
Bokonjic, D
Milovanovic, S
Marincic, D
Jovic, P
Knezevic, M
Jovanovic, M
机构：
[1] FAC VET, BELGRADE, YUGOSLAVIA
[2] MIL MED ACAD, YU-11002 BELGRADE, YUGOSLAVIA
[3] MIL TECH INST, BELGRADE, YUGOSLAVIA
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [41] NORMALIZATION OF HYPERCALCEMIA ASSOCIATED WITH A DECREASE IN RENAL CALCIUM REABSORPTION IN LEYDIG-CELL TUMOR-BEARING RATS TREATED WITH WR-2721
    HIRSCHELSCHOLZ, S
    CAVERZASIO, J
    RIZZOLI, R
    BONJOUR, JP
    JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01): : 319 - 322
  • [42] AMIFOSTINE (WR-2721) PROTECTS NORMAL HEMATOPOIETIC STEM-CELLS AGAINST CYCLOPHOSPHAMIDE DERIVATIVES TOXICITY WITHOUT COMPROMISING THEIR ANTILEUKEMIC EFFECTS
    DOUAY, L
    HU, C
    GIARRATANA, MC
    GORIN, NC
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : S14 - S16
  • [43] Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity: an in vitro study
    Moroni, M
    Porta, C
    Finotti, N
    RegazziBonora, M
    Bertorelli, L
    Borasio, E
    Greco, R
    Marzatico, F
    ONCOLOGY REPORTS, 1997, 4 (04) : 729 - 732
  • [44] THE PROTECTIVE EFFECT OF WR-2721 ON MYOCARDIAL ACTIVITY IN IRRADIATED RATS .1. ACTIVITY OF THE ISOLATED PERFUSED HEART
    DOBRIC, S
    MILOVANOVIC, S
    BOSKOVIC, B
    PROSTRAN, M
    MILOVANOVIC, G
    IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1990, 26 (01) : 63 - 67
  • [45] Flow cytometric estimation of the plasma membrane diversity of bone marrow cells in mice treated with WR-2721 and cyclophosphamide
    Mazur, L
    Augustynek, A
    Bochenek, M
    TOXICOLOGY, 2002, 171 (2-3) : 63 - 72
  • [46] THE PROTECTIVE EFFECT OF WR-2721 ON THE MYOCARDIAL ACTIVITY IN IRRADIATED RATS .2. ACTIVITY OF THE INSITU HEART PREPARATION
    DOBRIC, S
    BOSKOVIC, B
    MILOVANOVIC, S
    PROSTRAN, M
    IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1990, 26 (01) : 69 - 72
  • [47] A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma - An Eastern Cooperative Oncology Group Study (E8188)
    Gradishar, WJ
    Stephenson, P
    Glover, DJ
    Neuberg, DS
    Moore, MR
    Windschitl, HE
    Piel, I
    Abeloff, MD
    CANCER, 2001, 92 (10) : 2517 - 2522
  • [48] Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study
    De Souza, CA
    Santini, G
    Marino, G
    Nati, S
    Congiu, AM
    Vigorito, AC
    Damasio, E
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (07) : 791 - 798
  • [49] AMIFOSTINE (WR2721) CONFERS DNA PROTECTION TO IN VIVO CISPLATIN-TREATED MURINE PERIPHERAL BLOOD LEUKOCYTES
    Prieto Gonzalez, E. A.
    Fuchs, A. G.
    Sanchez, Gonzalez S.
    DOSE-RESPONSE, 2009, 7 (03): : 234 - 246
  • [50] CLINICAL-STUDY OF RADIOPROTECTIVE EFFECTS OF AMIFOSTINE (YM-08310, WR-2721) ON LONG-TERM OUTCOME FOR PATIENTS WITH CERVICAL-CANCER
    MITSUHASHI, N
    TAKAHASHI, I
    TAKAHASHI, M
    HAYAKAWA, K
    NIIBE, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03): : 407 - 411
12345